Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy.
A single-arm pilot study was designed to evaluate the effect of Probiotic-3 against symptoms associated with treatment-refractory ulcerative colitis. Twenty patients with mild to moderate colitis took three Probiotic-3 capsules, three times a day, for four weeks. The primary outcome measure was resolution of symptoms. In total, 45% of patients exhibited complete remission, with 10% …
